Skip to main content

Table 4 Result of process variables (in mean and SE for continuous data, number and percentage for count data)

From: PRECISE — pregabalin in addition to usual care: statistical analysis plan

 

Pregabalin (n = xxx)

Placebo (n = xxx)

Self-reported daily dose (mg/day)

  

 Week 1

xxx.x (xxx.x to xxx.x), n

xxx.x (xxx.x to xxx.x), n

 Week 2

xxx.x (xxx.x to xxx.x), n

xxx.x (xxx.x to xxx.x), n

 Week 3

xxx.x (xxx.x to xxx.x), n

xxx.x (xxx.x to xxx.x), n

 Week 4

xxx.x (xxx.x to xxx.x), n

xxx.x (xxx.x to xxx.x), n

 Week 5

xxx.x (xxx.x to xxx.x), n

xxx.x (xxx.x to xxx.x), n

 Week 6

xxx.x (xxx.x to xxx.x), n

xxx.x (xxx.x to xxx.x), n

 Week 7

xxx.x (xxx.x to xxx.x), n

xxx.x (xxx.x to xxx.x), n

 Week 8

xxx.x (xxx.x to xxx.x), n

xxx.x (xxx.x to xxx.x), n

Participants returning study medicines

n/N (%)

n/N (%)

Participants consuming ≥80 % prescribed dose

  

 Medication diary

n/N (%)

n/N (%)

 Returned medicine count

n/N (%)

n/N (%)

Assessment of participant blinding

  

 Pregabalin

n/N (%)

n/N (%)

 Placebo

n/N (%)

n/N (%)

 Don’t know

n/N (%)

n/N (%)

Treatment satisfaction

  

 Very dissatisfied

n/N (%)

n/N (%)

 Dissatisfied

n/N (%)

n/N (%)

 Neutral

n/N (%)

n/N (%)

 Satisfied

n/N (%)

n/N (%)

 Very satisfied

n/N (%)

n/N (%)